ECM Weekly (29th August 2021) - Imeik, Helen’s, Jenscare, Dingdang, Simplex, Hyundai Heavy
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
AmbioPharm (昂博制药) Pre-IPO: Peptide CDMO Leader Turning Licensor
AmbioPharm is a global leader in the peptide CDMO business and will further monetizing its expertise by collaborating with partners to develop...
Pre-IPO Ambio Pharmaceuticals - The Particularity of Peptide Drugs, the Strength and the Concerns
The article mainly analyzed Ambio Pharmaceuticals in terms of the particularity of peptide drugs & industry characteristics, the strength of its...
No more insights